Pneumologie 2020; 74(S 01): 84-86
DOI: 10.1055/s-0039-3403249
Freie Vorträge (FV12) – Sektion Klinische Pneumologie
Hot Topics der klinischen Pneumologie
Georg Thieme Verlag KG Stuttgart · New York

Hemodynamic phenotypes in patients with systemic sclerosis screened for pulmonary hypertension (PH) – the impact of the new defintion of PH

P Xanthouli
1   Centre for Pulmonary Hypertension, Thoraxklinik at Heidelberg University Hospital; Translational Lung Research Center Heidelberg (Tlrc), Member of the German Center for Lung Research (Dzl), Heidelberg, Germany
,
S Jordan
2   Department of Rheumatology, University Hospital Zurich
,
N Milde
3   Centre for Pulmonary Hypertension, Thoraxklinik at Heidelberg University Hospital; Translational Lung Research Center Heidelberg (Tlrc), Member of the German Center for Lung Research (Dzl), Heidelberg
,
AM Marra
4   Irccs Sdn, Naples, Italy
,
N Blank
5   Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg
,
B Egenlauf
1   Centre for Pulmonary Hypertension, Thoraxklinik at Heidelberg University Hospital; Translational Lung Research Center Heidelberg (Tlrc), Member of the German Center for Lung Research (Dzl), Heidelberg, Germany
,
M Gorenflo
6   Department of Pediatric Cardiology, University Hospital Heidelberg
,
S Harutyunova
1   Centre for Pulmonary Hypertension, Thoraxklinik at Heidelberg University Hospital; Translational Lung Research Center Heidelberg (Tlrc), Member of the German Center for Lung Research (Dzl), Heidelberg, Germany
,
HM Lorenz
5   Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg
,
C Nagel
7   Centre for Pulmonary Hypertension, Thoraxklinik at Heidelberg University Hospital, Translational Lung Research Center Heidelberg (Tlrc), Member of the German Center for Lung Research (Dzl), Heidelberg, Germany; Lung Centre, Klinikum Mittelbaden, Baden-Baden Balg, Germany
,
V Theobald
1   Centre for Pulmonary Hypertension, Thoraxklinik at Heidelberg University Hospital; Translational Lung Research Center Heidelberg (Tlrc), Member of the German Center for Lung Research (Dzl), Heidelberg, Germany
,
S Ulrich
8   Department of Pulmonology, University Hospital Zurich
,
E Grünig
1   Centre for Pulmonary Hypertension, Thoraxklinik at Heidelberg University Hospital; Translational Lung Research Center Heidelberg (Tlrc), Member of the German Center for Lung Research (Dzl), Heidelberg, Germany
,
N Benjamin
1   Centre for Pulmonary Hypertension, Thoraxklinik at Heidelberg University Hospital; Translational Lung Research Center Heidelberg (Tlrc), Member of the German Center for Lung Research (Dzl), Heidelberg, Germany
,
O Distler
2   Department of Rheumatology, University Hospital Zurich
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
28. Februar 2020 (online)

 

Background: In this study we investigated the impact of the new hemodynamic definition of pulmonary hypertension (PH) with mean pulmonary arterial pressure (mPAP) > 20 mmHg, pulmonary arterial wedge pressure ≤ 15 mmHg and pulmonary vascular resistance (PVR) ≥ 3 WU, as proposed by the 6th PH World Symposium in patients with systemic sclerosis (SSc).

Methods: In consecutive SSc-patients who were prospectively screened for PH including right heart catheterization in 2 PAH/SSc centers (Heidelberg and Zurich) hemodynamic and clinical variables have been reassessed according to the new PAH-definition. Long-term follow-up and survival analysis have been performed. Patients with significant lung or left heart disease were excluded from comparative analyses.

Results: The final dataset included 284 SSc-patients who have been followed for 3.7 ± 3.7 (median 3.4) years, 146 patients (49.2%) had mPAP ≤ 20 mmHg, 19.3% had mildly elevated mPAP (21 – 24 mmHg) and 29.4% had mPAP ≥ 25 mmHg ([Fig. 1]). In the group of mildly elevated mPAP, only four patients (1.4% of the whole SSc-cohort) had PVR-values ≥ 3WU and could be reclassified as manifest SSc-APAH according to the new definition. If a threshold for PVR ≥ 2WU would be used, 28 (9,85%) patients would have been newly diagnosed with PAH ([Fig. 2]). These patients (mPAP 21 – 24 mmHg, PVR ≥ 2WU) had already an early pulmonary vascular disease with reduced 6-minute walking distance (p < 0.001), tricuspid annular plane systolic excursion (p = 0.004), pulmonary arterial compliance (p < 0.001) and long-term survival (p = 0.002) ([Fig. 3]) compared to those with normal hemodynamic values.

Zoom Image
Fig. 1 Study flow chart.
Zoom Image
Fig. 2 Different PVR thresholds in patients with mPAP 21 – 24 mmHg and ≥ 25 mmHg.
Zoom Image
Fig. 3 Survival in different hemodynamic groups according to mPAP.

Conclusions: The new hemodynamic PAH definition did not have a significant impact on the diagnosis of PH. The data of this study suggest, that a PVR threshold > 3WU may be too high and significantly impairs the possibility of an early diagnosis with significant impact on survival ([Fig. 3]).